Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer


Cokmert S., Demir L., Can A., Akyol M., Bayoglu I. V. , Dirican A., ...More

JOURNAL OF BUON, vol.19, no.1, pp.75-82, 2014 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 1
  • Publication Date: 2014
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.75-82

Abstract

Purpose: Erythrocyte mean corpuscular volume (MCV) increase has been described in patients treated with capaecitabine. In this study, we sought to evaluate the potential association of the erythrocyte MCV increase with tumor response and survival in patients with metastatic colorectal cancer (mCRC) treated with capecitabine.